IBDEI2O2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44749,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,44749,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,44749,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,44750,0)
 ;;=R50.9^^200^2230^27
 ;;^UTILITY(U,$J,358.3,44750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44750,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,44750,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,44750,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,44751,0)
 ;;=R76.11^^200^2230^1
 ;;^UTILITY(U,$J,358.3,44751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44751,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,44751,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,44751,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,44752,0)
 ;;=Z21.^^200^2230^30
 ;;^UTILITY(U,$J,358.3,44752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44752,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,44752,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,44752,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,44753,0)
 ;;=B37.0^^200^2230^16
 ;;^UTILITY(U,$J,358.3,44753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44753,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,44753,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,44753,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,44754,0)
 ;;=B97.10^^200^2230^22
 ;;^UTILITY(U,$J,358.3,44754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44754,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,44754,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,44754,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,44755,0)
 ;;=R50.82^^200^2230^24
 ;;^UTILITY(U,$J,358.3,44755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44755,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,44755,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,44755,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,44756,0)
 ;;=R50.83^^200^2230^26
 ;;^UTILITY(U,$J,358.3,44756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44756,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,44756,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,44756,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,44757,0)
 ;;=R50.84^^200^2230^25
 ;;^UTILITY(U,$J,358.3,44757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44757,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,44757,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,44757,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,44758,0)
 ;;=B02.23^^200^2230^70
 ;;^UTILITY(U,$J,358.3,44758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44758,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,44758,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,44758,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,44759,0)
 ;;=B02.22^^200^2230^71
 ;;^UTILITY(U,$J,358.3,44759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44759,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,44759,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,44759,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,44760,0)
 ;;=J03.91^^200^2230^80
 ;;^UTILITY(U,$J,358.3,44760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44760,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,44760,1,4,0)
 ;;=4^J03.91
 ;;^UTILITY(U,$J,358.3,44760,2)
 ;;=^5008136
 ;;^UTILITY(U,$J,358.3,44761,0)
 ;;=K70.0^^200^2231^3
 ;;^UTILITY(U,$J,358.3,44761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44761,1,3,0)
 ;;=3^Alcoholic Fatty Liver
 ;;^UTILITY(U,$J,358.3,44761,1,4,0)
 ;;=4^K70.0
 ;;^UTILITY(U,$J,358.3,44761,2)
 ;;=^5008784
 ;;^UTILITY(U,$J,358.3,44762,0)
 ;;=K70.11^^200^2231^7
 ;;^UTILITY(U,$J,358.3,44762,1,0)
 ;;=^358.31IA^4^2
